ITRM Stock Summary and Trading Ideas (Iterum Therapeutics PLC - Ordinary Share | NASDAQ:ITRM)

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

Iterum Therapeutics PLC - Ordinary Share trades on the NASDAQ stock market under the symbol ITRM.

As of December 12, 2025, ITRM stock price declined to $0.45 with 516,876 million shares trading.

ITRM has a beta of 0.96, meaning it tends to be less sensitive to market movements. ITRM has a correlation of 0.06 to the broad based SPY ETF.

ITRM has a market cap of $23.75 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, ITRM traded as high as $3.02 and as low as $.36.

ITRM has underperformed the market in the last year with a price return of -77.3% while the SPY ETF gained +14.0%. ITRM has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -34.1% and -2.2%, respectively, while the SPY returned +4.0% and -0.2%, respectively.

ITRM support price is $.43 and resistance is $.51 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ITRM shares will trade within this expected range on the day.